Braskem (NYSE:BAK - Get Free Report) is expected to issue its quarterly earnings data before the market opens on Tuesday, March 18th. Analysts expect the company to announce earnings of $0.05 per share and revenue of $20.99 billion for the quarter. Parties that are interested in participating in the company's conference call can do so using this link.
Braskem (NYSE:BAK - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.01). Braskem had a negative net margin of 9.88% and a negative return on equity of 439.59%. The firm had revenue of $3.28 billion for the quarter, compared to the consensus estimate of $3.52 billion. On average, analysts expect Braskem to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Braskem Stock Up 1.8 %
BAK traded up $0.07 during trading on Tuesday, hitting $3.64. The company's stock had a trading volume of 763,090 shares, compared to its average volume of 818,870. Braskem has a one year low of $3.41 and a one year high of $10.98. The business's 50 day simple moving average is $4.25 and its 200-day simple moving average is $5.30. The firm has a market cap of $1.45 billion, a PE ratio of -1.02 and a beta of 2.06.
Wall Street Analysts Forecast Growth
Separately, Scotiabank cut Braskem from a "sector outperform" rating to a "sector perform" rating in a research report on Monday, March 3rd.
Get Our Latest Analysis on BAK
About Braskem
(
Get Free Report)
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Recommended Stories

Before you consider Braskem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.
While Braskem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.